Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Lyell Immunopharma, Inc. has filed 331 SEC EDGAR filings since 20 Mar 2020

SEC filing history

Showing 226-250 of 331 matching filings.

Per page
25
Current page
10
DEFA14A File 001-40502

FORM DEFA14A

Filing date
27 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Feb 2023
Reporting date
24 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Feb 2023
Reporting date
24 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Feb 2023
Reporting date
24 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Feb 2023
Reporting date
24 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Feb 2023
Reporting date
24 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-270145

S-8

Filing date
28 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-93402

SC 13G/A

Filing date
13 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-93402

SCHEDULE 13G

Filing date
09 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Dec 2022
Reporting date
15 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Oct 2022
Reporting date
10 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
03 Oct 2022
Reporting date
28 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Sep 2022
Reporting date
23 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Sep 2022
Reporting date
08 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-266548

S-3ASR

Filing date
04 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .